Contraceptive Patch Singapore Clinic

Contraceptive Patch Singapore Clinic: Ortho Evra® transdermal contraceptive patch clinic, Singapore. Hormonal contraceptive, for birth control and contraception. Definitions, references, and latest news.

Description

Evra® trandermal contraceptive patch is an innovative method of drug delivery for those who prefer not to take oral contraceptives. The first patch is applied on the first day of menstruation. Just one patch is applied per week for the first three weeks. This is followed by one patch free week.

References

• Contraceptive patch - Wikipedia, the free encyclopedia
• Contraceptive patch: Definition from Answers.com
• Contraceptive patch - definition of Contraceptive patch in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.
• Evra® package insert

Systemic photosensitivity due to a contraceptive patch
Mon, 12 Jul 2010 23:00:00 +0100 | Photodermatology, Photoimmunology and Photomedicine
We report a case of systemic photosensitivity induced by the contraceptive patch. To the best of our knowledge, no other cases induced by transdermal contraceptives have been reported previously. (Source: Photodermatology, Photoimmunology and Photomedicine)

Agile Therapeutics Secures $45M in Series B Funding to Progress Lead Contraceptive Patch, AG200-15, Through NDA Filing
Mon, 14 Jun 2010 13:07:25 +0100 | HSMN NewsFeed
Advances Second Contraceptive Patch, AG1000, into Phase 2 Clinical Development PRINCETON, N.J.--(HSMN NewsFeed)--Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women’s healthcare products, today announced that it completed... Biopharmaceuticals, Venture CapitalAgile Therapeutics (Source: HSMN NewsFeed)

Skin patch and vaginal ring versus combined oral contraceptives for contraception.
Sat, 20 Mar 2010 06:22:03 +0100 | Cochrane Database of Systematic Reviews
CONCLUSIONS: Effectiveness was similar for the methods compared. The patch could lead to more discontinuation while the vaginal ring showed little difference. The patch group had better compliance than the COC group but more side effects. Ring users generally had fewer adverse events than COC users but more vaginal irritation and discharge. High losses to follow up can affect the validity of the results. PMID: 20238323 [PubMed - in process] (Source: Cochrane Database of Systematic Reviews)

Contraceptive use among solid organ transplant patients: a systematic review
Fri, 19 Mar 2010 00:00:00 +0100 | Contraception
Conclusions: Very limited evidence on COC and transdermal contraceptive patch use among kidney and liver transplant recipients indicated no pregnancies and no overall changes in biochemical measures. Excluding case reports, evidence on other contraceptive methods or contraception among other types of solid organ transplants was not identified. (Source: Contraception)

Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users
Thu, 28 Jan 2010 17:59:54 +0100 | Archives of Gynecology and Obstetrics
Conclusion  This investigation observed an overall positive impression of Evra with good compliance among adolescent and adult users. This might be an effect of the convenience of the weekly dosing schedule. Compliance is of utmost importance in teenagers as this age group is at highest risk of unintended pregnancy. Content Type Journal ArticleCategory General GynecologyDOI 10.1007/s00404-010-1368-6Authors Klaus Bodner, Hospital Rudolfstiftung Department of Gynecology and Obstetrics Vienna AustriaBarbara Bodner-Adler, Al Ain Hospital Department of Gynecology and Obstetrics Al Ain United Arab EmiratesWerner Grünberger, Hospital Rudolfstiftung Department of Gynecology and Obstetrics Vienna Austria Journal Archives of Gynecology and ObstetricsOnline ISSN 1432-0711...

Ortho Evra (contraceptive patch)
Thu, 14 Jan 2010 02:45:01 +0100 | MayoClinic.com Full Feed
— Overview covers definition, risks, instructions for using this type of contraception. (Source: MayoClinic.com Full Feed)

Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study
Fri, 30 Oct 2009 00:00:00 +0100 | Contraception
This study was conducted to compare the effects of the combined contraceptive vaginal ring releasing 15 mcg of ethinylestradiol (EE) and 120 mcg of etonorgestrel daily with the effects of the contraceptive patch, a transdermal system that delivers a daily dose of 20 mcg of EE and 150 mcg of norelgestromin on bone turnover and bone mineral density (BMD) in young fertile women.Study Design: On the basis of a randomized, computer-generated list, 40 women desiring contraception were assigned to a 12-month treatment with a patch delivering a daily dose of 20 mcg of EE and 150 mcg of norelgestromin (Evra®, Janssen-Cilag, Italy) (Group A, n=20) or to a 12-month treatment with a vaginal ring releasing a daily dose of 15 mcg of EE and 120 mcg of etonorgestrel (NuvaRing®, Organon, Italy) (Group B,...

Estrogen patch suspected in student death
Wed, 21 Oct 2009 18:26:24 +0100 | Health News - UPI.com
BOSTON, Oct. 21 (UPI) -- A Boston woman whose teenage daughter died of a pulmonary embolism says she doesn't understand why the contraceptive patch Ortho Evra is still on the market. (Source: Health News - UPI.com)

Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy
Mon, 29 Jun 2009 23:00:00 +0100 | BMC Women's Health - Latest articles
Conclusions: This study demonstrated that the EE/NGMN patch is associated with high satisfaction levels and excellent compliance. At study end, the majority of women indicated that they would continue using the patch. (Source: BMC Women's Health - Latest articles)